Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHunting Regulatory News (HTG)

Share Price Information for Hunting (HTG)

Share Price is delayed by 15 minutes
Get Live Data
472.50    6.50 (1.39%)
Bid:
472.50
Ask:
473.00
Spread: 0.50 (0.106%)
Market Cap: £690.41m
HTG Live PriceLast checked at - London Stock Exchange

Intraday Hunting Share Chart

Cost Reduction Plan & Update to Capital Allocation

5 Mar 2026 07:02

RNS Number : 3876V
Hunting PLC
05 March 2026
 

For Immediate Release

5 March 2026

 

 

 

 

Hunting PLC

 

("Hunting" or "the Company" or "the Group")

 

Cost Reduction Plan

and

Update to Capital Allocation Priorities

 

Hunting PLC (LSE: HTG), the global precision engineering group, today provides an update to its cost reduction plans, as part of the Group's Hunting 2030 Strategy, in addition to updating investors on its ongoing capital allocation priorities.

 

Highlights

 

· Cost reduction plan to be completed through to the end of 2027 will increase profitability and further streamline centralised costs with projected savings of c.$15 million, in addition to those already announced.

· Proposed second Share Buyback programme, totalling $40 million, to be executed over two years up until March 2028.

 

Cost Reduction

 

Since 2024, Hunting has continued to maximise profitability through the significant restructuring of its Hunting Titan and EMEA operating segments. Costs of c.$20 million have been eliminated to date and will be realised by June 2026, once the Group's Fordoun, Aberdeen, operating site is closed.

 

In addition to these programmes, the Group implemented regional shared-service business functions in Q4 2025 in Europe and North America. This is expected to result in further ongoing SG&A cost savings. Other operational and centralised cost savings are also being pursued and are expected to result in additional savings of c.$15 million per annum by 2028.

 

Proposed New $40 million Share Buy Back Programme

 

The Directors have continued to review their capital allocation priorities and pursue bolt-on acquisitions and other growth opportunities. The Directors today announce the intention to complete a further $40 million Share Buyback programme. The new Share Buyback programme is to be completed over a two-year period, with c.$20 million per annum being targeted for completion, and the Share Buyback will be subject to pre-agreed parameters. This quantum of repurchases broadly matches the proposed dividend distributions in this timescale, with the Directors targeting a balanced capital allocation and return to shareholders over the next two years.

 

Commenting on the restructuring and updated capital allocation, Jim Johnson, Chief Executive of Hunting said:

 

"Our business remains focused on maximising profitability and cash generation, alongside pursuing our Hunting 2030 Strategy to deliver top line revenue growth through our key products and technology offering.

 

"In addition, the proposed new $40 million Share Buyback programme reflects our confidence in our cash generation and increases our returns to shareholders, providing an ambition which now extends to 2028."

 

For further information please contact:

 

Hunting PLC

Jim Johnson, Chief Executive

Bruce Ferguson, Finance Director

 

Tel: +44 (0) 20 7321 0123

Sodali & Co

James White

Tilly Abraham

Tel: +44 (0) 78 5543 2699

 

or

 

lon.IR@hunting-intl.com

 

About Hunting PLC

 

Hunting is a global, precision engineering group that provides precision-manufactured equipment and premium services, which add value for our customers. Established in 1874, it is a listed public company, quoted on the London Stock Exchange in the Equity Shares in Commercial Companies ("ESCC") category. The Company maintains a corporate office in Houston and is headquartered in London. As well as the United Kingdom, the Company has operations in China, India, Indonesia, Mexico, Saudi Arabia, Singapore, United Arab Emirates and the United States of America.

 

The Group reports in US dollars across five operating segments: Hunting Titan; North America; Subsea Technologies; Europe, Middle East and Africa ("EMEA"); and Asia Pacific.

 

The Group also reports revenue and EBITDA financial metrics based on five product groups: OCTG; Perforating Systems; Subsea; Advanced Manufacturing; and Other Manufacturing.

 

Hunting PLC's Legal Entity Identifier is 2138008S5FL78ITZRN66

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUSVBRNUUORAR
Date   Source Headline
30th May 20237:00 amRNSMajor OCTG order & revised 2023 full year guidance
19th May 202312:29 pmRNSDirectors Shareholding/PDMR transactions
16th May 20233:32 pmRNSDirector Shareholding/PDMR
5th May 20237:00 amRNSDirector/PDMR Shareholding
2nd May 202310:05 amRNSTR-1: Notification of major holdings
27th Apr 20233:35 pmRNSPayment of 2022 Final Dividend in Sterling
27th Apr 202312:56 pmRNSDirector Shareholding/PDMR
26th Apr 202311:44 amRNSTR-1: Notification of Major Holdings
20th Apr 20232:36 pmRNSReport on Payments to Govts
19th Apr 202312:54 pmRNSResult of AGM
19th Apr 20237:00 amRNSAGM and Q1 2023 Trading Update
21st Mar 202312:00 pmRNSDirectors Shareholding/PDMR Replacement
16th Mar 20234:00 pmRNSAnnual Report and Accounts 2022 and Notice of AGM
10th Mar 20234:39 pmRNSDirectors Shareholding/PDMR transactions
9th Mar 20233:45 pmRNSDirectors Shareholding/PDMR
9th Mar 20233:39 pmRNSDirectors Shareholding/PDMR
3rd Mar 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Mar 20237:01 amRNSLaunch of 2030 Strategy & Capital Markets Day
2nd Mar 20237:00 amRNSResults for the year ended 31 December 2022
26th Jan 20236:00 pmRNSMicro Focus International
26th Jan 20234:58 pmRNSTR-1: Notification Of Major Holdings
17th Jan 20237:00 amRNSAppointment of Joint Corporate Broker
3rd Jan 20237:00 amRNSAppointment of non-executive Director
15th Dec 20227:00 amRNSYear-End Trading Update
2nd Nov 202211:18 amRNSDirector Shareholding/PDMR
2nd Nov 202211:17 amRNSDirector Shareholding/PDMR
2nd Nov 202211:16 amRNSDirector Shareholding/PDMR
27th Oct 20227:00 amRNSQ3 2022 Trading Update
14th Oct 20224:00 pmRNSPayment of 2022 Interim Dividend in Sterling
5th Oct 20223:44 pmRNSDirector Shareholding/PDMR
29th Sep 20224:14 pmRNSDirector Declaration
12th Sep 202212:42 pmRNSTR-1: Notification Of Major Holdings
6th Sep 202210:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
25th Aug 20227:01 amRNSTrading Update
25th Aug 20227:00 amRNSUnaudited results for the six months to 30/06/22
5th Jul 20221:10 pmRNSPDMR Shareholding
30th Jun 20227:00 amRNSH1 2022 Trading Update
24th Jun 20227:00 amRNSChange of Registered Office
29th Apr 20224:00 pmRNSReport on Payments to Governments
28th Apr 20222:29 pmRNSPayment of 2021 Final Dividend in Sterling
20th Apr 20222:40 pmRNSResults of AGM and Directorate Change
20th Apr 20227:00 amRNSAGM and Q1 2022 Trading Update
5th Apr 20221:29 pmRNSTR-1: Notification of major holdings
28th Mar 20229:34 amRNSHolding(s) in Company
23rd Mar 20222:30 pmRNSDirector Shareholding / PDMR Transactions
17th Mar 20223:00 pmRNS2021 Annual Report and Accounts and Notice of AGM
16th Mar 20229:43 amRNSTR-1: Notification of Major Holdings
7th Mar 20224:00 pmRNSDirector Shareholding/PDMR Transactions
7th Mar 20224:00 pmRNSDirector/PDMR Shareholding
4th Mar 20229:41 amRNSDirectors Shareholding/PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.